Free Trial

Life Science REIT (LABS) Competitors

Life Science REIT logo
GBX 35 -0.20 (-0.57%)
As of 01/17/2025 12:28 PM Eastern

LABS vs. IHR, MXF, AGR, PHP, THRL, RDI, LOK, MTVW, PCTN, and WHR

Should you be buying Life Science REIT stock or one of its competitors? The main competitors of Life Science REIT include Impact Healthcare REIT (IHR), Medicx Fund (MXF), Assura (AGR), Primary Health Properties (PHP), Target Healthcare REIT (THRL), Rdi Reit (RDI), Lok'nStore Group (LOK), Mountview Estates (MTVW), Picton Property Income (PCTN), and Warehouse REIT (WHR). These companies are all part of the "real estate" sector.

Life Science REIT vs.

Life Science REIT (LON:LABS) and Impact Healthcare REIT (LON:IHR) are both small-cap real estate companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, community ranking, profitability, valuation and dividends.

In the previous week, Life Science REIT's average media sentiment score of 0.00 equaled Impact Healthcare REIT'saverage media sentiment score.

Company Overall Sentiment
Life Science REIT Neutral
Impact Healthcare REIT Neutral

Life Science REIT pays an annual dividend of GBX 2 per share and has a dividend yield of 5.7%. Impact Healthcare REIT pays an annual dividend of GBX 7 per share. Life Science REIT pays out -3,333.3% of its earnings in the form of a dividend. Impact Healthcare REIT pays out 6,363.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Life Science REIT is clearly the better dividend stock, given its higher yield and lower payout ratio.

Impact Healthcare REIT has a net margin of 88.90% compared to Life Science REIT's net margin of -108.85%. Impact Healthcare REIT's return on equity of 9.90% beat Life Science REIT's return on equity.

Company Net Margins Return on Equity Return on Assets
Life Science REIT-108.85% -7.20% 1.25%
Impact Healthcare REIT 88.90%9.90%4.30%

Life Science REIT presently has a consensus target price of GBX 46.50, suggesting a potential upside of 32.86%. Impact Healthcare REIT has a consensus target price of GBX 114, suggesting a potential upside of 0.00%. Given Life Science REIT's higher possible upside, equities research analysts clearly believe Life Science REIT is more favorable than Impact Healthcare REIT.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Life Science REIT
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67
Impact Healthcare REIT
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

67.3% of Life Science REIT shares are held by institutional investors. Comparatively, 59.5% of Impact Healthcare REIT shares are held by institutional investors. 7.0% of Life Science REIT shares are held by company insiders. Comparatively, 9.3% of Impact Healthcare REIT shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Impact Healthcare REIT received 42 more outperform votes than Life Science REIT when rated by MarketBeat users. However, 80.00% of users gave Life Science REIT an outperform vote while only 77.97% of users gave Impact Healthcare REIT an outperform vote.

CompanyUnderperformOutperform
Life Science REITOutperform Votes
4
80.00%
Underperform Votes
1
20.00%
Impact Healthcare REITOutperform Votes
46
77.97%
Underperform Votes
13
22.03%

Impact Healthcare REIT has higher revenue and earnings than Life Science REIT. Life Science REIT is trading at a lower price-to-earnings ratio than Impact Healthcare REIT, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Life Science REIT£19.94M6.14-£21.71M-£0.06-583.33
Impact Healthcare REIT£53.51M0.00£47.58M£0.11N/A

Life Science REIT has a beta of 0.08, indicating that its stock price is 92% less volatile than the S&P 500. Comparatively, Impact Healthcare REIT has a beta of 0.37, indicating that its stock price is 63% less volatile than the S&P 500.

Summary

Impact Healthcare REIT beats Life Science REIT on 11 of the 17 factors compared between the two stocks.

Get Life Science REIT News Delivered to You Automatically

Sign up to receive the latest news and ratings for LABS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LABS vs. The Competition

MetricLife Science REITREIT IndustryReal Estate SectorLON Exchange
Market Cap£122.50M£1.39B£1.57B£2.06B
Dividend Yield6.21%7.38%6.51%5.16%
P/E Ratio-583.33115.97227.701,943.78
Price / Sales6.14468.08277.92427,090.66
Price / CashN/A49.2267.9629.43
Price / Book0.431.221.243.10
Net Income-£21.71M-£70.23M-£46.67M£158.20M
7 Day Performance0.86%1.27%1.07%3.24%
1 Month Performance-8.38%-1.10%-0.34%3.38%
1 Year Performance-42.24%-5.40%2.31%168.76%

Life Science REIT Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LABS
Life Science REIT
N/AGBX 35
-0.6%
GBX 46.50
+32.9%
-42.2%£122.50M£19.94M-583.33N/A
IHR
Impact Healthcare REIT
N/AN/AGBX 114
+∞
N/A£361.75M£53.51M793.64N/A
MXF
Medicx Fund
N/AN/AN/AN/A£0.00N/A0.00N/AHigh Trading Volume
AGR
Assura
3.114 of 5 stars
GBX 36.28
+0.4%
GBX 50.67
+39.7%
-17.0%£1.18B£157.80M-3,628.0084
PHP
Primary Health Properties
1.4163 of 5 stars
GBX 86.64
+0.6%
GBX 107.50
+24.1%
-4.5%£1.16B£177.80M-8,664.0058News Coverage
Gap Up
THRL
Target Healthcare REIT
N/AGBX 81.30
+0.6%
N/A+0.2%£504.26M£69.55M677.50N/ANews Coverage
RDI
Rdi Reit
N/AN/AN/AN/A£462.34M£68.40M-4.442,020
LOK
Lok'nStore Group
N/AN/AN/AN/A£356.58M£27.73M8,500.00193
MTVW
Mountview Estates
N/AGBX 8,750
-2.8%
N/A-7.5%£341.25M£79.47M1,200.2729Dividend Cut
News Coverage
Gap Up
PCTN
Picton Property Income
N/AGBX 60.40
+0.2%
N/A+0.0%£329.76M£54.69M-6,040.0010News Coverage
WHR
Warehouse REIT
2.7855 of 5 stars
GBX 76.40
+0.4%
GBX 108
+41.4%
-2.1%£324.59M£51.03M955.0061,000Gap Up

Related Companies and Tools


This page (LON:LABS) was last updated on 1/19/2025 by MarketBeat.com Staff
From Our Partners